Paper · 46249
Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities.
Skidmore BJ and 3 others. J Immunol, 1975. Cited by 259 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. Papers, record 46249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46249
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipopolysaccharides | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Adjuvants, Immunologic | |
| Animals | |
| B-Lymphocytes | |
| Escherichia coli | |
| Immune Tolerance | |
| Lymphocyte Activation | |
| Mice | |
| Mice, Inbred A | |
| Mice, Inbred C3H | |
| Mitogens | |
| Serum Albumin, Bovine | |
| gamma-Globulins |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 259 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,851,097 | Carriers and Antigens: New Developments in Glycoconjugate Vaccines. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36851097 | PubMed |
| 36,007,249 | Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines. | Anal Chem | 2022 | https://conductscience.org/library/papers/36007249 | PubMed |
| 35,883,511 | Kinetic Changes in B7 Costimulatory Molecules and IRF4 Expression in Human Dendritic Cells during LPS Exposure. | Biomolecules | 2022 | https://conductscience.org/library/papers/35883511 | PubMed |
| 34,561,306 | Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34561306 | PubMed |
| 34,368,643 | Bacteria-Inspired Nanomedicine. | ACS Appl Bio Mater | 2021 | https://conductscience.org/library/papers/34368643 | PubMed |
| 33,794,238 | A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients. | Int J Biol Macromol | 2021 | https://conductscience.org/library/papers/33794238 | PubMed |
| 32,788,381 | A Novel High-Potency Tetanus Vaccine. | mBio | 2020 | https://conductscience.org/library/papers/32788381 | PubMed |
| 29,373,896 | Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System | Asian Pac J Cancer Prev | 2018 | https://conductscience.org/library/papers/29373896 | PubMed |
| 27,133,257 | Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders. | Biomol Ther (Seoul) | 2016 | https://conductscience.org/library/papers/27133257 | PubMed |
| 25,480,508 | Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues. | Adv Carbohydr Chem Biochem | 2014 | https://conductscience.org/library/papers/25480508 | PubMed |
1 to 10 of 76
See all 76 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46249
GET https://conductscience.org/api/papers/v1/46249/cited_by?page=2